Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$4.05
-0.5%
$4.95
$0.86
$6.08
$320.64M0.5144,019 shs71,184 shs
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$20.00
$19.98
$12.26
$20.57
$843.96M0.74765,906 shs4,300 shs
Pulmonx Co. stock logo
LUNG
Pulmonx
$7.46
+2.2%
$9.20
$7.11
$14.84
$287.51M0.6498,020 shs12,394 shs
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$13.16
+0.5%
$13.71
$9.57
$21.60
$492.32M1.04402,244 shs51,404 shs
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$213.56
+1.9%
$220.49
$127.29
$257.29
$1.63B0.8362,883 shs4,156 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
-1.93%-10.55%-20.82%-9.96%+266.67%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.00%0.00%0.00%0.00%+0.15%
Pulmonx Co. stock logo
LUNG
Pulmonx
-2.93%-2.67%-18.80%-45.52%-37.55%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-3.39%+0.61%-3.82%-9.28%-28.88%
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
-2.21%-3.72%-12.87%+25.74%+53.59%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bioventus Inc. stock logo
BVS
Bioventus
3.1202 of 5 stars
3.50.00.00.00.64.21.9
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.2823 of 5 stars
0.00.00.04.20.01.70.6
Pulmonx Co. stock logo
LUNG
Pulmonx
2.2457 of 5 stars
3.43.00.00.01.42.50.6
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.6765 of 5 stars
2.01.00.00.01.81.71.3
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
2.3472 of 5 stars
2.33.00.00.02.72.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioventus Inc. stock logo
BVS
Bioventus
3.00
Buy$7.6789.30% Upside
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/A
Pulmonx Co. stock logo
LUNG
Pulmonx
2.83
Moderate Buy$15.83112.24% Upside
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2.00
Hold$15.5017.78% Upside
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
2.50
Moderate Buy$238.5011.68% Upside

Current Analyst Ratings

Latest CSII, BVS, LUNG, OFIX, and UFPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
4/3/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$17.00
3/20/2024
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
CJS Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$255.00
3/13/2024
Bioventus Inc. stock logo
BVS
Bioventus
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$6.00 ➝ $9.00
3/7/2024
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$12.00 ➝ $15.00
2/23/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $17.00
2/23/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$16.00 ➝ $14.00
2/22/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$13.00 ➝ $17.00
2/22/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $17.00
2/22/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$15.00 ➝ $16.00
2/6/2024
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Weight
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioventus Inc. stock logo
BVS
Bioventus
$512.34M0.63$0.77 per share5.25$2.80 per share1.45
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$239.84M3.52N/AN/A$6.12 per share3.27
Pulmonx Co. stock logo
LUNG
Pulmonx
$68.68M4.19N/AN/A$3.09 per share2.41
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$746.64M0.66N/AN/A$16.11 per share0.82
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$400.07M4.08$7.70 per share27.73$37.45 per share5.70

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioventus Inc. stock logo
BVS
Bioventus
-$156.23M-$2.52N/A10.13N/A-30.49%2.25%0.62%5/21/2024 (Estimated)
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
-$36.93M-$0.97N/AN/AN/A-15.79%-15.39%-11.93%N/A
Pulmonx Co. stock logo
LUNG
Pulmonx
-$60.84M-$1.60N/AN/AN/A-88.60%-46.63%-32.14%5/1/2024 (Confirmed)
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$151.40M-$4.14N/AN/AN/A-20.28%-10.63%-7.34%5/7/2024 (Confirmed)
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$44.92M$5.8536.5131.50N/A11.23%25.48%17.04%5/7/2024 (Estimated)

Latest CSII, BVS, LUNG, OFIX, and UFPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$0.32N/A+$0.32N/AN/AN/A  
5/1/2024N/A
Pulmonx Co. stock logo
LUNG
Pulmonx
-$0.43N/A+$0.43N/AN/AN/A  
3/12/2024Q4 2023
Bioventus Inc. stock logo
BVS
Bioventus
$0.06$0.07+$0.01$0.24$124.84 million$135.42 million
3/5/2024Q4 2023
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$0.60-$0.59+$0.01-$0.59N/A$200.42 million    
2/21/2024Q4 2023
Pulmonx Co. stock logo
LUNG
Pulmonx
-$0.38-$0.36+$0.02-$0.36$18.24 million$19.30 million    
2/21/2024Q4 2023
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$1.12$1.53+$0.41$1.55$94.80 million$101.50 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/AN/A
Pulmonx Co. stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
N/AN/AN/AN/AN/A
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioventus Inc. stock logo
BVS
Bioventus
1.66
1.53
1.01
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.08
6.04
4.92
Pulmonx Co. stock logo
LUNG
Pulmonx
0.30
6.50
5.77
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.19
2.54
1.20
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
0.10
2.48
1.28

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
86.61%
Pulmonx Co. stock logo
LUNG
Pulmonx
91.04%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
89.76%
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
87.28%

Insider Ownership

CompanyInsider Ownership
Bioventus Inc. stock logo
BVS
Bioventus
29.10%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
3.80%
Pulmonx Co. stock logo
LUNG
Pulmonx
5.70%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
4.70%
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
7.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bioventus Inc. stock logo
BVS
Bioventus
97079.17 million56.13 millionNot Optionable
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
78042.20 million40.59 millionOptionable
Pulmonx Co. stock logo
LUNG
Pulmonx
27938.54 million36.34 millionOptionable
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1,63437.41 million35.65 millionOptionable
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
3,2937.64 million7.05 millionOptionable

CSII, BVS, LUNG, OFIX, and UFPT Headlines

SourceHeadline
UFP Technologies, Inc. (NASDAQ:UFPT) Holdings Trimmed by Calamos Advisors LLCUFP Technologies, Inc. (NASDAQ:UFPT) Holdings Trimmed by Calamos Advisors LLC
marketbeat.com - April 21 at 6:21 AM
Knights of Columbus Asset Advisors LLC Boosts Position in UFP Technologies, Inc. (NASDAQ:UFPT)Knights of Columbus Asset Advisors LLC Boosts Position in UFP Technologies, Inc. (NASDAQ:UFPT)
marketbeat.com - April 20 at 8:53 AM
Allspring Global Investments Holdings LLC Decreases Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)Allspring Global Investments Holdings LLC Decreases Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)
marketbeat.com - April 19 at 4:50 AM
Granite Bay Wealth Management LLC Decreases Stock Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)Granite Bay Wealth Management LLC Decreases Stock Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)
marketbeat.com - April 14 at 12:14 PM
Impax Asset Management Group plc Sells 21,000 Shares of UFP Technologies, Inc. (NASDAQ:UFPT)Impax Asset Management Group plc Sells 21,000 Shares of UFP Technologies, Inc. (NASDAQ:UFPT)
marketbeat.com - April 11 at 8:00 AM
UFP Technologies (UFPT) Outperformed in Q1 With 47% GainUFP Technologies (UFPT) Outperformed in Q1 With 47% Gain
insidermonkey.com - April 10 at 6:01 AM
UFP Technologies (NASDAQ:UFPT) Trading Down 4.1%UFP Technologies (NASDAQ:UFPT) Trading Down 4.1%
marketbeat.com - April 9 at 1:50 PM
UFP Technologies, Inc. (NASDAQ:UFPT) Shares Sold by Assenagon Asset Management S.A.UFP Technologies, Inc. (NASDAQ:UFPT) Shares Sold by Assenagon Asset Management S.A.
marketbeat.com - April 7 at 4:36 AM
Vanguard Group Inc. Boosts Stock Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)Vanguard Group Inc. Boosts Stock Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)
marketbeat.com - April 6 at 4:15 AM
UFP Technologies (NASDAQ:UFPT) Hits New 52-Week High at $250.69UFP Technologies (NASDAQ:UFPT) Hits New 52-Week High at $250.69
marketbeat.com - March 27 at 2:41 PM
UFP Technologies (NASDAQ:UFPT) five-year earnings growth trails the enviable shareholder returnsUFP Technologies' (NASDAQ:UFPT) five-year earnings growth trails the enviable shareholder returns
finance.yahoo.com - March 23 at 3:30 PM
Chimerix Appoints Marc D. Kozin to Board of DirectorsChimerix Appoints Marc D. Kozin to Board of Directors
finance.yahoo.com - March 21 at 9:31 AM
UFP Technologies Inc.UFP Technologies Inc.
money.usnews.com - March 21 at 4:31 AM
UFP Technologies Stock Rises 8% With Manufacturing Supply AgreementUFP Technologies Stock Rises 8% With Manufacturing Supply Agreement
marketwatch.com - March 20 at 4:58 AM
UFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor ForumUFP Technologies to Present and Host 1X1 Investor Meetings at the KeyBanc Capital Markets 4th Annual Life Sciences and MedTech Investor Forum
globenewswire.com - March 19 at 9:00 AM
UFPT Apr 2024 150.000 putUFPT Apr 2024 150.000 put
finance.yahoo.com - March 16 at 5:33 PM
Insider Selling: UFP Technologies, Inc. (NASDAQ:UFPT) VP Sells 311 Shares of StockInsider Selling: UFP Technologies, Inc. (NASDAQ:UFPT) VP Sells 311 Shares of Stock
insidertrades.com - March 16 at 10:36 AM
Heres Why We Think UFP Technologies (NASDAQ:UFPT) Might Deserve Your Attention TodayHere's Why We Think UFP Technologies (NASDAQ:UFPT) Might Deserve Your Attention Today
finance.yahoo.com - March 9 at 10:19 AM
UFP Technologies (UFPT) Price Target Increased by 22.87% to 235.62UFP Technologies (UFPT) Price Target Increased by 22.87% to 235.62
msn.com - February 25 at 7:32 AM
UFP Technologies, Inc. (NASDAQ:UFPT) Just Reported And Analysts Have Been Lifting Their Price TargetsUFP Technologies, Inc. (NASDAQ:UFPT) Just Reported And Analysts Have Been Lifting Their Price Targets
finance.yahoo.com - February 24 at 12:24 PM
UFPT Jul 2024 150.000 callUFPT Jul 2024 150.000 call
finance.yahoo.com - February 23 at 4:16 PM
UFP Technologies price target raised by $43 at Lake Street, heres whyUFP Technologies price target raised by $43 at Lake Street, here's why
realmoney.thestreet.com - February 23 at 9:57 AM
UFP Technologies Full Year 2023 Earnings: EPS Beats ExpectationsUFP Technologies Full Year 2023 Earnings: EPS Beats Expectations
finance.yahoo.com - February 23 at 9:57 AM
Analysts Are Bullish on These Healthcare Stocks: ClearPoint Neuro (CLPT), Apollo Medical Holdings (AMEH)Analysts Are Bullish on These Healthcare Stocks: ClearPoint Neuro (CLPT), Apollo Medical Holdings (AMEH)
markets.businessinsider.com - February 23 at 12:38 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bioventus logo

Bioventus

NYSE:BVS
Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.
Cardiovascular Systems logo

Cardiovascular Systems

NASDAQ:CSII
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.
Pulmonx logo

Pulmonx

NASDAQ:LUNG
Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Orthofix Medical logo

Orthofix Medical

NASDAQ:OFIX
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
UFP Technologies logo

UFP Technologies

NASDAQ:UFPT
UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.